论文部分内容阅读
我们于1983年12月～1985年5月应用长效雌激素(炔雌醚)治疗因化疗、放疗所致的粒细胞减少患者49例,并与目前常用的升白药对照,发现长效雌激素有较好的升白作用。现总结报道如下。材料与方法一般资料:两组病例均为肺癌、淋巴瘤、胃肠肿瘤、骨肉瘤的患者。长效雌激素组(简称治疗组)共49例,常用升白药组(简称对照组)共
We December 1983 ~ May 1985 application of long-acting estrogen (ethinylestradiol) treatment of chemotherapy-induced radiotherapy-induced neutropenia in 49 patients with the current commonly used ascending medicine contrast and found that long-acting estrogen Better whitening effect. Now summarized as follows. Materials and Methods General Information: Two groups of patients were lung cancer, lymphoma, gastrointestinal cancer, osteosarcoma patients. Long-acting estrogen group (referred to as the treatment group) a total of 49 cases, commonly used Baiyao group (referred to as the control group) were